BE803461A - Production d'esters de steroides - Google Patents

Production d'esters de steroides

Info

Publication number
BE803461A
BE803461A BE134445A BE134445A BE803461A BE 803461 A BE803461 A BE 803461A BE 134445 A BE134445 A BE 134445A BE 134445 A BE134445 A BE 134445A BE 803461 A BE803461 A BE 803461A
Authority
BE
Belgium
Prior art keywords
steroids
esters
production
Prior art date
Application number
BE134445A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of BE803461A publication Critical patent/BE803461A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Steroid Compounds (AREA)
BE134445A 1972-08-11 1973-08-10 Production d'esters de steroides BE803461A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3765572A GB1440063A (en) 1972-08-11 1972-08-11 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids

Publications (1)

Publication Number Publication Date
BE803461A true BE803461A (fr) 1974-02-11

Family

ID=10398029

Family Applications (1)

Application Number Title Priority Date Filing Date
BE134445A BE803461A (fr) 1972-08-11 1973-08-10 Production d'esters de steroides

Country Status (16)

Country Link
US (1) US3891631A (fr)
JP (1) JPS5752359B2 (fr)
BE (1) BE803461A (fr)
CA (1) CA1027109A (fr)
CH (1) CH590884A5 (fr)
DE (1) DE2340591A1 (fr)
DK (1) DK135998B (fr)
ES (1) ES417738A1 (fr)
FR (1) FR2205508B1 (fr)
GB (1) GB1440063A (fr)
IE (1) IE38312B1 (fr)
IL (1) IL42942A (fr)
LU (1) LU68212A1 (fr)
NL (1) NL7311072A (fr)
SE (1) SE387951B (fr)
ZA (2) ZA735452B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1516095A (en) * 1974-07-31 1978-06-28 Glaxo Lab Ltd 17,21-diesters of 17alpha,21-dihydroxy-steroids of the pregnane series
GB1593978A (en) * 1976-12-31 1981-07-22 Lark Spa Anti-inflammatory steroids
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
DE2759135A1 (de) * 1977-12-30 1979-07-19 Lark Spa Neue steroidverbindungen und deren herstellung und verwendung
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
JPS58161340A (ja) * 1982-03-19 1983-09-24 Hitachi Ltd 製品移送装置
AU558725B2 (en) * 1983-09-07 1987-02-05 Mitsubishi Kasei Corporation Corticoid derivatives
JPH0527014Y2 (fr) * 1985-10-31 1993-07-08
DE3637806A1 (de) * 1986-11-06 1988-05-19 Hoechst Ag Verfahren zur herstellung von prednisolon-17-ethylcarbonat durch umlagerung von prednisolon-21-ethylcarbonat
FR2683530B1 (fr) * 1991-11-08 1994-01-21 Roussel Uclaf Nouveau procede de preparation de derives 20-oxo 17 alpha, 21-dihydroxyles du pregnane et nouveaux intermediaires.
BRPI0113042B8 (pt) * 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
BR0209271A (pt) * 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
EP3656385A1 (fr) 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Modulateurs stéroïdiens non hormonaux de nf-kb pour le traitement d'une maladie
WO2011127048A2 (fr) 2010-04-05 2011-10-13 Validus Biopharma MODULATEURS STÉROÏDES NON HORMONAUX DE NF-ĸB POUR LE TRAITEMENT DE MALADIES
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255218A (en) * 1962-03-28 1966-06-07 Schering Corp 17(20)-enol-21-aldehydes of the pregnane series
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato

Also Published As

Publication number Publication date
DK135998C (fr) 1977-12-27
ES417738A1 (es) 1976-06-16
JPS4985062A (fr) 1974-08-15
ZA735453B (en) 1974-10-30
NL7311072A (fr) 1974-02-13
DK135998B (da) 1977-07-25
GB1440063A (en) 1976-06-23
IL42942A (en) 1977-05-31
CA1027109A (fr) 1978-02-28
IE38312B1 (en) 1978-02-15
FR2205508B1 (fr) 1978-09-15
ZA735452B (en) 1974-07-31
IL42942A0 (en) 1973-11-28
AU5914373A (en) 1975-02-13
CH590884A5 (fr) 1977-08-31
IE38312L (en) 1974-02-11
SE387951B (sv) 1976-09-20
JPS5752359B2 (fr) 1982-11-06
LU68212A1 (fr) 1973-10-16
US3891631A (en) 1975-06-24
DE2340591A1 (de) 1974-03-07
FR2205508A1 (fr) 1974-05-31

Similar Documents

Publication Publication Date Title
BE803461A (fr) Production d'esters de steroides
JPS5625176A (en) Manufacture of novel quinaxaline or quinazoline derivative
ZA739408B (en) Esters of 3-hydroxyindone compounds
IT977039B (it) Procedimento per la produzione di monosaccardi per separazione da miscele che includono trisac caridi disaccaridi ed oligosac caridi
JPS5543081A (en) Manufacture of 2*1*33benzothiadiazole derivative
SE399423B (sv) Forfarande for framstellning av prostaglandinanaloger
BE764496A (fr) Production d'esters
BE798485A (fr) Production d'esters
BE766002R (fr) Procede de preparation d'esters carboxyliques du type
BE805354A (fr) Production de fibrilles
SE392609B (sv) Forfarande for framstellning av metanhaltiga gaser
BE769464A (fr) Procede de production d'esters d'antibiotiques b-5050 et de tetrahydro-b-5050
BG24817A3 (en) Method of obtaining esters of a-aminoacylcephalosporin
BE760034A (fr) Production d'esters
CA1010894A (en) Production of unsaturated esters
SE398750B (sv) Forfarande for framstellning av metylamino-2-metyl-4'-piperazinyl-4-klor-6-metyltio-5-pyrimidin
JPS56115766A (en) Manufacture of cyanomethylthioacetic acids
ZA739298B (en) Process for the manufacture of pregnane acids
BE806163A (fr) Production de la di-4-chlorophenylsulfone
RO69492A2 (fr) Procede pour la preparation de perchlore-methyle-mercaptane
JPS5699460A (en) Manufacture of 2*66diaminoodihydropyridines
BE794467A (fr) Procede de production d'ergosterol et de ses esters
SE420198B (sv) Forfarande for framstellning av p-bifenylestrar av vissa 15-substituerade w-pentanorprosglandiner ur e- och f-serierna
IT976903B (it) Procedimento per la produzione di 2 mercaptobenzimidazolo
IT997554B (it) Procedimento per la produzione di 2 5 esandione